Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acco Brands | ACCO | Dec 24, 2024 | 5.27 | -0.38 |
Accolade | ACCD | Dec 24, 2024 | 3.40 | -1.45 |
Accuray | ARAY | Dec 24, 2024 | 1.94 | +3.74 |
Acelyrin | SLRN | Dec 24, 2024 | 3.17 | -0.31 |
Achieve Life Sciences | ACHV | Dec 24, 2024 | 3.79 | +0.26 |
Achilles Therapeutics ADR | ACHL | Dec 24, 2024 | 1.14 | +16.18 |
ACI Worldwide | ACIW | Dec 24, 2024 | 52.89 | +1.50 |
Aclarion | ACON | Dec 24, 2024 | 0.13 | +1.11 |
Aclaris Therapeutics | ACRS | Dec 24, 2024 | 2.90 | +0.35 |
ACM Research A | ACMR | Dec 24, 2024 | 15.38 | +0.59 |
Acme United | ACU | Dec 24, 2024 | 36.95 | -0.11 |
ACNB | ACNB | Dec 24, 2024 | 40.77 | -1.62 |
ACRES Commercial Realty | ACR | Dec 24, 2024 | 15.80 | +2.20 |
ACRES Commercial Realty C Pref | ACR-C | Dec 24, 2024 | 25.15 | +0.08 |
ACRES Commercial Realty D Pref | ACR-D | Dec 24, 2024 | 22.98 | +0.79 |
Acrivon Therapeutics | ACRV | Dec 24, 2024 | 6.23 | -2.04 |
Actelis Networks | ASNS | Dec 24, 2024 | 1.15 | -1.71 |
Actinium Pharmaceuticals | ATNM | Dec 24, 2024 | 1.22 | -1.61 |
Active Bear ETF | HDGE | Dec 24, 2024 | 16.13 | -0.49 |
Active U.S. Real Estate Powershares | PSR | Dec 24, 2024 | 90.65 | +0.73 |
Actuate Therapeutics | ACTU | Dec 24, 2024 | 7.53 | +10.25 |
Acuity Brands | AYI | Dec 24, 2024 | 303.16 | +0.27 |
Acumen Pharmaceuticals | ABOS | Dec 24, 2024 | 1.79 | +1.13 |
Acurx Pharmaceuticals | ACXP | Dec 24, 2024 | 0.88 | +6.90 |
Acushnet | GOLF | Dec 24, 2024 | 70.74 | +0.41 |
ACV Auctions A | ACVA | Dec 24, 2024 | 21.67 | +1.17 |
ACWI Ex-US Index MSCI Ishares | ACWX | Dec 24, 2024 | 52.60 | +0.36 |
ACWI Index MSCI Ishares | ACWI | Dec 24, 2024 | 119.85 | +0.84 |
Adagene ADR | ADAG | Dec 24, 2024 | 1.94 | +3.19 |
Adagio Medical | ADGM | Dec 24, 2024 | 0.97 | -10.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.